Company Name: Minomic’s Mi-Check test for prostate cancer – 4 times more accurate than PSA testing
Announcement Date: 21/07/2016
Announcement Category: Product launch/update
Announcement Content:
Australian biotech company Minomic has developed a non-invasive test, Mi-Check, to detect prostate cancer. PSA testing typically returns 6 false positive results out of 10, resulting in unnecessary biopsies, meaning stress, pain and the risk of infection. Trials indicate Mi-Check returns just 1.5 false positives out of 10. Please watch Minomic's CEO, Dr Brad Walsh, for more details.
Announcement URL: http://bit.ly/29WG238
About Minomic’s Mi-Check test for prostate cancer – 4 times more accurate than PSA testing:
Go to Company Profile for: Minomic’s Mi-Check test for prostate cancer – 4 times more accurate than PSA testing
Announcement Contact: deanf@monsoon.com.au
